Cargando…

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia

Detalles Bibliográficos
Autores principales:	Hampel, Paul J., Parikh, Sameer A., Call, Timothy G., Shah, Mithun V., Bennani, N. Nora, Al-Kali, Aref, Rabe, Kari G., Wang, Yucai, Muchtar, Eli, Leis, Jose F., Kenderian, Saad S., Koehler, Amber B., Schwager, Susan M., Slager, Susan L., Kay, Neil E., Hanson, Curtis A., Van Dyke, Daniel L., Shi, Min, Ding, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925672/ https://www.ncbi.nlm.nih.gov/pubmed/33654067 http://dx.doi.org/10.1038/s41408-021-00443-1

Ejemplares similares

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center
por: Wang, Yucai, et al.
Publicado: (2020)

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
por: Parikh, Sameer A., et al.
Publicado: (2021)

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
por: Hampel, Paul J., et al.
Publicado: (2022)

The role of (18)F-FDG-PET in detecting Richter transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor
por: Wang, Yucai, et al.
Publicado: (2020)

P1094: CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF PATIENTS WITH T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AT A LARGE TERTIARY CARE CENTER
por: Audil, H., et al.
Publicado: (2022)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia
por: Kornauth, Christoph, et al.
Publicado: (2021)

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
por: Parikh, Sameer A., et al.
Publicado: (2020)

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
por: King, Rebecca L., et al.
Publicado: (2022)

Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia
por: Tian, Shulan, et al.
Publicado: (2021)

Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax
por: Siddiqui, Maria Tariq, et al.
Publicado: (2021)

P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Hwang, Steven, et al.
Publicado: (2023)

Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia
por: Gangat, Naseema, et al.
Publicado: (2022)

Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms
por: Shah, Mithun Vinod, et al.
Publicado: (2022)

T-cell Prolymphocytic Leukemia, Cerebriform Variant
por: Carvalho, José, et al.
Publicado: (2021)

Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL
por: Griffin, Rosalie, et al.
Publicado: (2023)

Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents
por: Johnson, Isla M., et al.
Publicado: (2022)

T-cell Prolymphocytic Leukemia Presenting as Red Eye
por: Alwadani, Fahad
Publicado: (2011)

Advances in the understanding and management of T-cell prolymphocytic leukemia
por: Laribi, Kamel, et al.
Publicado: (2017)

An illustrative case of B-cell prolymphocytic leukemia
por: Jain, Ankur, et al.
Publicado: (2020)

Bilateral tonsillar infiltration of T‐cell prolymphocytic leukemia
por: Bertaggia, Ilaria, et al.
Publicado: (2019)

Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia
por: Varadarajan, Indumathy, et al.
Publicado: (2022)

De-Novo B-Cell Prolymphocytic Leukemia
por: Menakuru, Sasmith R., et al.
Publicado: (2023)

T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment
por: Gutierrez, Marc, et al.
Publicado: (2023)

Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy
por: Gangat, Naseema, et al.
Publicado: (2023)

An Association Between Hypoplastic Myelodysplastic Syndrome and T-Prolymphocytic Leukaemia
por: Arathi, C A, et al.
Publicado: (2011)

T-cell Prolymphocytic Leukemia with Cutaneous Involvement as the Presenting Feature
por: Ashturkar, Amrut V, et al.
Publicado: (2012)

T‐cell prolymphocytic leukemia and tuberculosis: a puzzling association
por: Cervera, Pascale, et al.
Publicado: (2017)

SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
por: Johansson, Patricia, et al.
Publicado: (2018)

T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches
por: Colon Ramos, Ana, et al.
Publicado: (2021)

Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)
por: Salama, Youssef, et al.
Publicado: (2022)

Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)
por: Solomon, Benjamin M., et al.
Publicado: (2015)

Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm
por: Gangat, Naseema, et al.
Publicado: (2022)

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
por: Joshi, Maansi, et al.
Publicado: (2021)

Bullous leukemia cutis in a patient with T-cell prolymphocytic leukemia
por: Siu, Sarah Y., et al.
Publicado: (2016)

Small cell variant of T-cell prolymphocytic leukemia with atypical presentation
por: Park, Joowon
Publicado: (2018)

Auer Rod-Like Inclusions in B-Cell Prolymphocytic Leukemia
por: Zhao, Yantian, et al.
Publicado: (2019)

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Braun, Till, et al.
Publicado: (2021)

Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis
por: Geres, Hana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q9b2r2p0lblfmfhpbr4rvv567u